CM
ISEE

Caption Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Caption Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-212,100
Closed -$3.81M – 1856
2022
Q3 		$3.81M Buy
+212,100
New +$2.78M 0.05% 429

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Caption Management's ISEE Position: Q3 2022 in Review

Caption Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2022, closing a stake of 112,605 shares — an estimated $1.48M sold.

Caption Management first reported a position in ISEE in Q3 2021 and held it in 2 quarters. The position peaked at $1.08M in Q2 2022. 213 funds tracked by Wall St. Rank hold ISEE as of Q3 2022.

  • Caption Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Caption Management sold 112,605 IVERIC bio, Inc. Common Stock shares in Q3 2022, an estimated $1.48M.
  • Caption Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Caption Management's IVERIC bio, Inc. Common Stock position peaked at $1.08M in Q2 2022.
  • 213 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2022.

Based on Caption Management's 13F filing for Q3 2022, filed 14 Nov 2022.